Company intelligence / Profile preview

Virpax Pharmaceuticals

Berwyn, Pennsylvania, USAvirpaxpharma.com ↗
Ownership
Public · VRPX
Development stage
Other
01

Overview

Virpax Pharmaceuticals develops non-addictive therapeutics for severe pain, CNS disorders, and viral infections using advanced drug delivery platforms. Lead program Probudur has shown promising preclinical results with extended post-surgical analgesia and reduced opioid need. Envelta demonstrated analgesic potential without tolerance or reward-seeking behavior in animal models. NobrXiol leverages MET for intranasal CBD delivery targeting rare pediatric epilepsy with FDA PIND guidance received. AnQlar showed strong antiviral activity against influenza/COVID in preclinical studies.

Therapeutic areas
NeurologyInfectious DiseasesRheumatology
Modalities
Small molecules (e.g., bupivacaine)Peptides (enkephalin analogs)Cannabinoids (CBD)Nanoparticle/liposomal formulations
Industry
Biotech
02

Drug pipeline

12 assets

epoladerm

Approved

11 more assets in the full pipeline.

03

Partnerships

National Institutes of Health/National Center for Advancing Translational Sciences—CRADA on EnveltaDepartment of Defense—CRADA on select candidatesNanomerics Ltd.—technology licensing partner for MET platform
04

Financials

Market cap
$373
Total revenue
$0
Enterprise value
$-1.5M

Beyond the preview

Go deeper on Virpax Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virpax Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call